Mahmood Nazar M Shareef, Mahmood Almas M R, Maulood Ismail M
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region Iraq.
Cytotechnology. 2025 Apr;77(2):55. doi: 10.1007/s10616-025-00720-y. Epub 2025 Feb 5.
In a circadian cycle, the pineal gland produces and releases melatonin (MEL) into the bloodstream. By activating distinct melatonin receptors, MEL has been shown to variably change vascular endothelial dysfunction (VED) to various vascular beds. This study investigates the interaction of melatonin (MEL) and potassium ion (K) on angiotensin 1-7 (Ang 1-7) vasorelaxant in streptozotocin (STZ)-induced diabetes mellitus (DM) and non-diabetes mellitus (non-DM) male albino rat aortic rings. The isometric tension of isolated aortic rings was assessed by generating a dose-response curve (DRC) for Ang 1-7 using a PowerLab data acquisition system. Accordingly, three experimental sets were carried out. In the first set the aortic rings were exposed MEL and MEL agonist ramelteon (RAM) and MEL antagonist luzindole (LUZ). In the second set, the aortic rings were exposed to various non-selective calcium activated potassium channel (K) blockers, including tetraethylammonium (TEA), a small and large-conductance calcium-activated K [(SK) and (BK)] channels blocker charybdotoxin (ChTx) and intermediate calcium-activated K channel (IK) blocker clotrimazole (CLT). In the third set, the aortic rings were exposed to various selective K channels blockers, including the selective blocker of K channel, glibenclamide (Glib), 4-aminopyridine (4-AP), a selective blocker of K channels and BaCl, delayed inward rectifier K channels (K) blocker. The results highlight the significant role of MEL in modulating vascular reactivity, particularly in the DM aorta. By enhancing the vasorelaxant effects of Ang 1-7 through mechanisms involving its receptors and antioxidant activities, MEL demonstrates its potential to counteract oxidative stress and VED associated with diabetes. These findings advance the understanding of vascular reactivity in diabetes and suggest MEL as a promising therapeutic agent for improving vascular health in diabetic conditions.
在昼夜节律周期中,松果体产生褪黑素(MEL)并将其释放到血液中。通过激活不同的褪黑素受体,MEL已被证明可不同程度地改变不同血管床的血管内皮功能障碍(VED)。本研究调查了褪黑素(MEL)和钾离子(K)对链脲佐菌素(STZ)诱导的糖尿病(DM)和非糖尿病(非DM)雄性白化大鼠主动脉环中血管紧张素1-7(Ang 1-7)血管舒张作用的相互影响。使用PowerLab数据采集系统生成Ang 1-7的剂量反应曲线(DRC),评估离体主动脉环的等长张力。据此,进行了三组实验。第一组中,主动脉环分别暴露于MEL、MEL激动剂雷美替胺(RAM)和MEL拮抗剂鲁辛朵(LUZ)。第二组中,主动脉环分别暴露于各种非选择性钙激活钾通道(K)阻滞剂,包括四乙铵(TEA)、小电导和大电导钙激活钾[(SK)和(BK)]通道阻滞剂蝎毒素(ChTx)以及中间钙激活钾通道(IK)阻滞剂克霉唑(CLT)。第三组中,主动脉环分别暴露于各种选择性K通道阻滞剂,包括K通道选择性阻滞剂格列本脲(Glib)、4-氨基吡啶(4-AP)、K通道选择性阻滞剂以及BaCl、延迟整流钾通道(K)阻滞剂。结果突出了MEL在调节血管反应性方面的重要作用,尤其是在糖尿病主动脉中。通过涉及其受体和抗氧化活性的机制增强Ang 1-7的血管舒张作用,MEL显示出其抵消与糖尿病相关的氧化应激和VED的潜力。这些发现增进了对糖尿病中血管反应性的理解,并表明MEL作为改善糖尿病患者血管健康的一种有前景的治疗药物。